Yıl: 2021 Cilt: 29 Sayı: 2 Sayfa Aralığı: 94 - 97 Metin Dili: İngilizce DOI: 10.5336/caserep.2020-79977 İndeks Tarihi: 14-05-2022

Isotretinoin Treatment-Induced Sacroiliitis

Öz:
Isotretinoin, which is commonly used for the treatment of severe and treatment-resistant acne vulgaris, is associated with many adverse effects including musculoskeletal pain and arthralgia, and rarely sacroiliitis. Isotretinoin-induced sacroiliitis is typically limited with the discontinuation of isotretinoin and usually reduces with non-steroidal anti-inflammatory drugs. In this article, we present a patient using isotretinoin for her facial acne, lived inflammatory pain in her lower back and right hip region after 8 weeks of isotiretionin treatment and diagnosed sacroiliitis. As a result we want to draw attention to the fact that this drug can cause low back pain and sacroiliitis as a side effect.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • 1. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33. Erratum in: J Am Acad Dermatol. 2020; 82(6):1576. [Crossref] [Pubmed]
  • 2. Nesher G, Zuckner J. Rheumatologic complications of vitamin A and retinoids. Semin Arthritis Rheum. 1995;24(4):291-6. [Crossref] [Pubmed]
  • 3. Çakır T, Subaşı V, Bi̇lgi̇li̇ A, Demi̇rdal ÜS, Ülker RN. A case with bilateral sacroiliitis and polyneuropathy development due to isotretinoin use. Arch Rheumatol. 2014;29(4): 304-8. [Crossref]
  • 4. Aydog E, Ozturk G, Comert A, Tasdelen N, Akin O, Kulcu DG. Sacroiliitis during isotretinoin treatment: Causal association or coincidence? North Clin Istanb. 2018;6(1):75- 80. [Pubmed] [PMC]
  • 5. Yılmazer B, Coşan F, Cefle A. Bilateral acute sacroiliitis due to isotretinoin therapy: a case report. Int J Rheum Dis. 2013;16(5):604-5. [Crossref] [Pubmed]
  • 6. Yilmaz Tasdelen O, Yurdakul FG, Duran S, Bodur H. Isotretinoin-induced arthritis mimicking both rheumatoid arthritis and axial spondyloarthritis. Int J Rheum Dis. 2015;18(4):466-9. [Crossref] [Pubmed]
  • 7. Alkan S, Kayiran N, Zengin O, Kalem A, Kimyon G, Kilinc EO, et al. Isotretinoininduced spondyloarthropathy-related symptoms: a prospective study. J Rheumatol. 2015;42(11):2106-9. [Crossref] [Pubmed]
  • 8. Baykal Selçuk L, Aksu Arıca D, Baykal Şahin H, Yaylı S, Bahadır S. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin. Cutan Ocul Toxicol. 2017;36(2):176-9. [Crossref] [Pubmed]
  • 9. Slobodin G, Hussein H, Rosner I, Eshed I. Sacroiliitis - early diagnosis is key. J Inflamm Res. 2018;11:339-44. [Crossref] [Pubmed] [PMC]
  • 10. Karadağ ŞG, Sönmez HE, Tanatar A, Çakan M, Aktay Ayaz N. Isotretinoin-induced sacroiliitis: Case series of four patients and a systematic review of the literature. Pediatr Dermatol. 2020;37(1):171-5. [Crossref] [Pubmed]
  • 11. Dinçer Ü, Çakar E, Kıralp MZ, Dursun H. Can isotretinoin induce sacroiliitis: three cases. Romatizma. 2008;23(4):157-9. [Link]
  • 12. Eksioglu E, Oztekin F, Unlu E, Cakci A, Keyik B, Karadavut IK. Sacroiliitis and polyneuropathy during isotretinoin treatment. Clin Exp Dermatol. 2008;33(2):122-4. [Crossref] [Pubmed]
  • 13. Dawoud NM, Elnady BM, Elkhouly T, Yosef A. Adalimumab as a successful treatment for acne fulminans and bilateral acute sacroiliitis with hip synovitis complicating isotretinoin therapy. Indian J Dermatol Venereol Leprol. 2018;84(1):104-7. [Crossref] [Pubmed]
  • 14. Coskun BN, Yagiz B, Pehlivan Y, Dalkilic E. Isotretinoin-induced sacroiliitis in patients with hidradenitis suppurativa: a case-based review. Rheumatol Int. 2019;39(12):2159-65. [Crossref] [Pubmed]
  • 15. Buchanan BK, Varacallo M. Sacroiliitis. 2020 Aug 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. [Pubmed]
APA GÖKBEL T, Gozpinar G, Dursun N, Dursun E (2021). Isotretinoin Treatment-Induced Sacroiliitis. , 94 - 97. 10.5336/caserep.2020-79977
Chicago GÖKBEL Tuğba,Gozpinar Guler,Dursun Nigar,Dursun Erbil Isotretinoin Treatment-Induced Sacroiliitis. (2021): 94 - 97. 10.5336/caserep.2020-79977
MLA GÖKBEL Tuğba,Gozpinar Guler,Dursun Nigar,Dursun Erbil Isotretinoin Treatment-Induced Sacroiliitis. , 2021, ss.94 - 97. 10.5336/caserep.2020-79977
AMA GÖKBEL T,Gozpinar G,Dursun N,Dursun E Isotretinoin Treatment-Induced Sacroiliitis. . 2021; 94 - 97. 10.5336/caserep.2020-79977
Vancouver GÖKBEL T,Gozpinar G,Dursun N,Dursun E Isotretinoin Treatment-Induced Sacroiliitis. . 2021; 94 - 97. 10.5336/caserep.2020-79977
IEEE GÖKBEL T,Gozpinar G,Dursun N,Dursun E "Isotretinoin Treatment-Induced Sacroiliitis." , ss.94 - 97, 2021. 10.5336/caserep.2020-79977
ISNAD GÖKBEL, Tuğba vd. "Isotretinoin Treatment-Induced Sacroiliitis". (2021), 94-97. https://doi.org/10.5336/caserep.2020-79977
APA GÖKBEL T, Gozpinar G, Dursun N, Dursun E (2021). Isotretinoin Treatment-Induced Sacroiliitis. Türkiye Klinikleri Journal of Case Reports, 29(2), 94 - 97. 10.5336/caserep.2020-79977
Chicago GÖKBEL Tuğba,Gozpinar Guler,Dursun Nigar,Dursun Erbil Isotretinoin Treatment-Induced Sacroiliitis. Türkiye Klinikleri Journal of Case Reports 29, no.2 (2021): 94 - 97. 10.5336/caserep.2020-79977
MLA GÖKBEL Tuğba,Gozpinar Guler,Dursun Nigar,Dursun Erbil Isotretinoin Treatment-Induced Sacroiliitis. Türkiye Klinikleri Journal of Case Reports, vol.29, no.2, 2021, ss.94 - 97. 10.5336/caserep.2020-79977
AMA GÖKBEL T,Gozpinar G,Dursun N,Dursun E Isotretinoin Treatment-Induced Sacroiliitis. Türkiye Klinikleri Journal of Case Reports. 2021; 29(2): 94 - 97. 10.5336/caserep.2020-79977
Vancouver GÖKBEL T,Gozpinar G,Dursun N,Dursun E Isotretinoin Treatment-Induced Sacroiliitis. Türkiye Klinikleri Journal of Case Reports. 2021; 29(2): 94 - 97. 10.5336/caserep.2020-79977
IEEE GÖKBEL T,Gozpinar G,Dursun N,Dursun E "Isotretinoin Treatment-Induced Sacroiliitis." Türkiye Klinikleri Journal of Case Reports, 29, ss.94 - 97, 2021. 10.5336/caserep.2020-79977
ISNAD GÖKBEL, Tuğba vd. "Isotretinoin Treatment-Induced Sacroiliitis". Türkiye Klinikleri Journal of Case Reports 29/2 (2021), 94-97. https://doi.org/10.5336/caserep.2020-79977